| Dr Felicia Michelle Ward, MD | |
|
10350 Highway 977, Maringouin, LA 70757 | |
| (225) 802-5769 | |
| Not Available |
| Full Name | Dr Felicia Michelle Ward |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 10350 Highway 977, Maringouin, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902824683 | NPI | - | NPPES |
| 1050563 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 25991 (Louisiana) | Secondary |
| 207R00000X | Internal Medicine | MD. 025991 (Louisiana) | Primary |
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
The House of Delegates of the Florida Medical Association is scheduled to consider a resolution severing ties with the American Medical Association because of its support for the healthcare reform law. The Florida group will consider the move at its annual meeting next month. The scathing resolution takes the AMA to task for having 'failed to achieve one single concession' in the healthcare reform bill.
Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, is pleased to announce that the Center for Discovery and Innovation has created a test to dramatically reduce the time it takes for diagnosing COVID-19.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, is pleased to announce that an Investigational New Drug application (IND) for Neutrolin was submitted to the United States Food and Drug Administration on Wednesday, September 24, 2014.
Application Security, Inc., the leading provider of database security, risk and compliance solutions for the enterprise, today announced that Humana Inc. has successfully implemented DbProtect™ to manage and safeguard the highly sensitive, critical information stored on its database servers.
Chemicals produced by healthy bacteria could be used to assess the health of the gut microbiome and help identify critically-ill children at greatest risk of organ failure, a study published in Critical Care Medicine has found.
› Verified 2 days ago
| Entity Name | Ambassador Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134237068 PECOS PAC ID: 7810099090 Enrollment ID: O20070219000160 |
News Archive
The House of Delegates of the Florida Medical Association is scheduled to consider a resolution severing ties with the American Medical Association because of its support for the healthcare reform law. The Florida group will consider the move at its annual meeting next month. The scathing resolution takes the AMA to task for having 'failed to achieve one single concession' in the healthcare reform bill.
Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, is pleased to announce that the Center for Discovery and Innovation has created a test to dramatically reduce the time it takes for diagnosing COVID-19.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, is pleased to announce that an Investigational New Drug application (IND) for Neutrolin was submitted to the United States Food and Drug Administration on Wednesday, September 24, 2014.
Application Security, Inc., the leading provider of database security, risk and compliance solutions for the enterprise, today announced that Humana Inc. has successfully implemented DbProtect™ to manage and safeguard the highly sensitive, critical information stored on its database servers.
Chemicals produced by healthy bacteria could be used to assess the health of the gut microbiome and help identify critically-ill children at greatest risk of organ failure, a study published in Critical Care Medicine has found.
› Verified 2 days ago
| Entity Name | St. Martin Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528312584 PECOS PAC ID: 0446495410 Enrollment ID: O20130321000353 |
News Archive
The House of Delegates of the Florida Medical Association is scheduled to consider a resolution severing ties with the American Medical Association because of its support for the healthcare reform law. The Florida group will consider the move at its annual meeting next month. The scathing resolution takes the AMA to task for having 'failed to achieve one single concession' in the healthcare reform bill.
Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, is pleased to announce that the Center for Discovery and Innovation has created a test to dramatically reduce the time it takes for diagnosing COVID-19.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, is pleased to announce that an Investigational New Drug application (IND) for Neutrolin was submitted to the United States Food and Drug Administration on Wednesday, September 24, 2014.
Application Security, Inc., the leading provider of database security, risk and compliance solutions for the enterprise, today announced that Humana Inc. has successfully implemented DbProtect™ to manage and safeguard the highly sensitive, critical information stored on its database servers.
Chemicals produced by healthy bacteria could be used to assess the health of the gut microbiome and help identify critically-ill children at greatest risk of organ failure, a study published in Critical Care Medicine has found.
› Verified 2 days ago
| Entity Name | Coolidge Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609298843 PECOS PAC ID: 7113156035 Enrollment ID: O20140218001309 |
News Archive
The House of Delegates of the Florida Medical Association is scheduled to consider a resolution severing ties with the American Medical Association because of its support for the healthcare reform law. The Florida group will consider the move at its annual meeting next month. The scathing resolution takes the AMA to task for having 'failed to achieve one single concession' in the healthcare reform bill.
Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, is pleased to announce that the Center for Discovery and Innovation has created a test to dramatically reduce the time it takes for diagnosing COVID-19.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, is pleased to announce that an Investigational New Drug application (IND) for Neutrolin was submitted to the United States Food and Drug Administration on Wednesday, September 24, 2014.
Application Security, Inc., the leading provider of database security, risk and compliance solutions for the enterprise, today announced that Humana Inc. has successfully implemented DbProtect™ to manage and safeguard the highly sensitive, critical information stored on its database servers.
Chemicals produced by healthy bacteria could be used to assess the health of the gut microbiome and help identify critically-ill children at greatest risk of organ failure, a study published in Critical Care Medicine has found.
› Verified 2 days ago
| Entity Name | Hub City Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992180566 PECOS PAC ID: 3173831211 Enrollment ID: O20151009000080 |
News Archive
The House of Delegates of the Florida Medical Association is scheduled to consider a resolution severing ties with the American Medical Association because of its support for the healthcare reform law. The Florida group will consider the move at its annual meeting next month. The scathing resolution takes the AMA to task for having 'failed to achieve one single concession' in the healthcare reform bill.
Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, is pleased to announce that the Center for Discovery and Innovation has created a test to dramatically reduce the time it takes for diagnosing COVID-19.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, is pleased to announce that an Investigational New Drug application (IND) for Neutrolin was submitted to the United States Food and Drug Administration on Wednesday, September 24, 2014.
Application Security, Inc., the leading provider of database security, risk and compliance solutions for the enterprise, today announced that Humana Inc. has successfully implemented DbProtect™ to manage and safeguard the highly sensitive, critical information stored on its database servers.
Chemicals produced by healthy bacteria could be used to assess the health of the gut microbiome and help identify critically-ill children at greatest risk of organ failure, a study published in Critical Care Medicine has found.
› Verified 2 days ago
| Entity Name | Centerwell Senior Primary Care La Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760005136 PECOS PAC ID: 1951712280 Enrollment ID: O20210217000212 |
News Archive
The House of Delegates of the Florida Medical Association is scheduled to consider a resolution severing ties with the American Medical Association because of its support for the healthcare reform law. The Florida group will consider the move at its annual meeting next month. The scathing resolution takes the AMA to task for having 'failed to achieve one single concession' in the healthcare reform bill.
Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, is pleased to announce that the Center for Discovery and Innovation has created a test to dramatically reduce the time it takes for diagnosing COVID-19.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, is pleased to announce that an Investigational New Drug application (IND) for Neutrolin was submitted to the United States Food and Drug Administration on Wednesday, September 24, 2014.
Application Security, Inc., the leading provider of database security, risk and compliance solutions for the enterprise, today announced that Humana Inc. has successfully implemented DbProtect™ to manage and safeguard the highly sensitive, critical information stored on its database servers.
Chemicals produced by healthy bacteria could be used to assess the health of the gut microbiome and help identify critically-ill children at greatest risk of organ failure, a study published in Critical Care Medicine has found.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Felicia Michelle Ward, MD Po Box 99, Maringouin, LA 70757-0099 Ph: (225) 802-5769 | Dr Felicia Michelle Ward, MD 10350 Highway 977, Maringouin, LA 70757 Ph: (225) 802-5769 |
News Archive
The House of Delegates of the Florida Medical Association is scheduled to consider a resolution severing ties with the American Medical Association because of its support for the healthcare reform law. The Florida group will consider the move at its annual meeting next month. The scathing resolution takes the AMA to task for having 'failed to achieve one single concession' in the healthcare reform bill.
Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, is pleased to announce that the Center for Discovery and Innovation has created a test to dramatically reduce the time it takes for diagnosing COVID-19.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, is pleased to announce that an Investigational New Drug application (IND) for Neutrolin was submitted to the United States Food and Drug Administration on Wednesday, September 24, 2014.
Application Security, Inc., the leading provider of database security, risk and compliance solutions for the enterprise, today announced that Humana Inc. has successfully implemented DbProtect™ to manage and safeguard the highly sensitive, critical information stored on its database servers.
Chemicals produced by healthy bacteria could be used to assess the health of the gut microbiome and help identify critically-ill children at greatest risk of organ failure, a study published in Critical Care Medicine has found.
› Verified 2 days ago